The Role of Uncultivated Bacteria in Bacterial Vaginosis

未培养的细菌在细菌性阴道病中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The microbiota of the human vagina can profoundly affect the health of women and neonates. For instance, women with the condition bacterial vaginosis (BV) have increased risks of acquiring sexually transmitted infections such as HIV, developing pelvic inflammatory disease, and experiencing preterm birth. Healthcare costs associated with BV are enormous, whether considering the direct costs related to the millions of healthcare visits annually for vaginal discharge, or the indirect costs such as care of pre-term infants. Despite recent advances that have used molecular methods (PCR) to better describe the microbiology of BV, there is a lack of understanding regarding why some women develop this condition. Changes in the vaginal microbiota after women develop BV are well described, but the microbiological, physiological, and behavioral antecedents to BV are poorly understood and connected. This proposal seeks to overcome this knowledge gap by collecting data on women at risk for BV in a longitudinal study designed to capture incident and relapsing cases. Broad range 16S rRNA gene PCR with pyrosequencing and bacterium-specific quantitative PCR will be used to characterize vaginal microbiotas. Changes in vaginal bacterial communities will be linked to physiological factors (menses), medication use (hormonal contraceptives, antibiotics), and behavioral factors (sexual practices, condom use). Studying the factors that lead to BV is critical for understanding pathogenesis. This knowledge can be used to develop improved methods for diagnosis, prevention, and treatment. Although antibiotics such as metronidazole and clindamycin can be used to treat BV, recurrence is common, with recurrence rates of up to 30% at 3 months and >50% at one year. The reasons for this high rate of recurrence are not known. High relapse rates complicate efforts to ameliorate the adverse health consequences of BV. This proposal seeks to describe the microbiological factors associated with recurrence of BV by studying extra-vaginal reservoirs of bacteria that may allow seeding of the vagina. Women with BV (and a subset of sex partners) will be followed during and after antibiotic treatment to assess concentrations of vaginal bacteria in vaginal and extra-vaginal sites using PCR. It is anticipated that colonization of extra-vaginal reservoirs will be a major risk factor for recurrence of BV. There is ongoing debate whether biofilms are important in the pathogenesis of BV, with intriguing data supporting this concept based on some small cross-sectional studies. Fluorescence in situ hybridization (FISH) will be used to assess the prevalence of bacterial biofilms in vaginal samples obtained from women with and without BV. The value of non-biopsy samples will be studied here. Changes in vaginal bacterial biofilms will be assessed after antibiotic treatment to determine if recurrence of BV is associated with persistence of bacteria in biofilm communities. If biofilms are shown to be important in BV, this would open many new avenues for treatment and prevention based on disruption of biofilm formation and cell signaling.
描述(由申请人提供):人类阴道的微生物群可以深刻影响妇女和新生儿的健康。例如,患有细菌性阴道病(BV)的妇女获得性传播感染(如艾滋病毒)、患上盆腔炎和早产的风险增加。无论是考虑到每年数百万因阴道分泌物就诊的直接费用,还是考虑到照顾早产儿等间接费用,与细菌性阴道炎相关的医疗费用都是巨大的。尽管最近的进展已经使用分子方法(PCR)来更好地描述细菌性阴道炎的微生物学,但对于为什么有些妇女会出现这种情况,人们缺乏了解。女性发生细菌性阴道炎后阴道微生物群的变化已被很好地描述,但细菌性阴道炎的微生物、生理和行为前因却知之甚少。这项建议旨在通过一项纵向研究来收集有感染细菌性阴阳炎风险的妇女的数据,从而克服这一知识差距。广泛范围16S rRNA基因PCR与焦磷酸测序和细菌特异性定量PCR将用于表征阴道微生物。阴道细菌群落的变化与生理因素(月经)、药物使用(激素避孕药、抗生素)和行为因素(性行为、避孕套使用)有关。研究导致细菌性阴道炎的因素对了解其发病机制至关重要。这些知识可用于改进诊断、预防和治疗方法。虽然可以使用甲硝唑和克林霉素等抗生素治疗细菌性肠胃炎,但复发是常见的,3个月复发率高达30%,1年复发率为50%。复发率如此之高的原因尚不清楚。高复发率使改善细菌性阴道炎不良健康后果的努力复杂化。这一建议旨在通过研究阴道外可能允许阴道播种的细菌库来描述与细菌性阴道炎复发相关的微生物因素。在抗生素治疗期间和之后,将对感染细菌性阴道炎的妇女(以及一部分性伴侣)进行随访,使用聚合酶链反应评估阴道和阴道外部位的阴道细菌浓度。预计阴道外蓄水池的定植将是BV复发的主要危险因素。生物膜在细菌性肠胃炎的发病机制中是否重要仍在争论中,基于一些小型横断面研究的有趣数据支持了这一概念。荧光原位杂交(FISH)将用于评估从患有和不患有细菌性阴道炎的妇女获得的阴道样本中细菌生物膜的患病率。这里将研究非活检样本的价值。抗生素治疗后将评估阴道细菌生物膜的变化,以确定细菌性阴道炎的复发是否与生物膜群落中细菌的持续存在有关。如果生物膜在细菌性胃炎中发挥重要作用,这将为基于破坏生物膜形成和细胞信号传导的治疗和预防开辟许多新的途径。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of Metronidazole on Concentrations of Vaginal Bacteria Associated with Risk of HIV Acquisition.
甲硝唑对与艾滋病毒感染风险相关的阴道细菌浓度的影响。
  • DOI:
    10.21203/rs.3.rs-4219764/v1
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Valint,DJ;Fiedler,TinaL;Liu,Congzhou;Srinivasan,Sujatha;Fredricks,DavidN
  • 通讯作者:
    Fredricks,DavidN
Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex With Men.
  • DOI:
    10.1093/infdis/jiaa233
  • 发表时间:
    2022-04-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fredricks DN;Plantinga A;Srinivasan S;Oot A;Wiser A;Fiedler TL;Proll S;Wu MC;Marrazzo JM
  • 通讯作者:
    Marrazzo JM
The human vaginal bacterial biota and bacterial vaginosis.
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria.
细菌性阴道病女性的细菌群落:高分辨率系统发育分析揭示了微生物群与临床标准的关系。
  • DOI:
    10.1371/journal.pone.0037818
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Srinivasan S;Hoffman NG;Morgan MT;Matsen FA;Fiedler TL;Hall RW;Ross FJ;McCoy CO;Bumgarner R;Marrazzo JM;Fredricks DN
  • 通讯作者:
    Fredricks DN
More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis.
  • DOI:
    10.1371/journal.pone.0078633
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Srinivasan S;Morgan MT;Liu C;Matsen FA;Hoffman NG;Fiedler TL;Agnew KJ;Marrazzo JM;Fredricks DN
  • 通讯作者:
    Fredricks DN
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID Neal FREDRICKS其他文献

DAVID Neal FREDRICKS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID Neal FREDRICKS', 18)}}的其他基金

Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation
粪便微生物群移植和纤维治疗造血细胞移植后移植物抗宿主病
  • 批准号:
    10737446
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
ANAEROBE 2022: the 16th Biennial Congress of the Anaerobe Society of the Americas (ASA)
厌氧菌 2022:第 16 届美洲厌氧菌协会 (ASA) 双年度大会
  • 批准号:
    10464618
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10668432
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10220681
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10471222
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10593458
  • 财政年份:
    2017
  • 资助金额:
    $ 79.42万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10287495
  • 财政年份:
    2017
  • 资助金额:
    $ 79.42万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10053303
  • 财政年份:
    2017
  • 资助金额:
    $ 79.42万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    8672151
  • 财政年份:
    2014
  • 资助金额:
    $ 79.42万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    9001246
  • 财政年份:
    2014
  • 资助金额:
    $ 79.42万
  • 项目类别:

相似海外基金

Identification and isolation of anaerobic bacteria that degrade bacterial cell wall
降解细菌细胞壁的厌氧菌的鉴定与分离
  • 批准号:
    22H02487
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Enzymology of cofactor and amino acid metabolism in anaerobic bacteria
厌氧菌辅助因子和氨基酸代谢的酶学
  • 批准号:
    RGPIN-2022-03200
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidating the mechanisms of O2-sensitivity of anaerobic bacteria Bifidobacterium.
阐明厌氧菌双歧杆菌的 O2 敏感性机制。
  • 批准号:
    22K07058
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
High-throughput isolation of anaerobic bacteria
厌氧菌的高通量分离
  • 批准号:
    572711-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
    University Undergraduate Student Research Awards
Automatic and accurate identification of aerobic bacteria, anaerobic bacteria, yeasts, and fungi in clinical samples derived from animals and from feed for pets
自动、准确地鉴定来自动物和宠物饲料的临床样品中的需氧细菌、厌氧细菌、酵母菌和真菌
  • 批准号:
    10440741
  • 财政年份:
    2021
  • 资助金额:
    $ 79.42万
  • 项目类别:
Regulation of virulence in fungi under coculture condition with anaerobic bacteria
厌氧菌共培养条件下真菌毒力的调节
  • 批准号:
    21K07009
  • 财政年份:
    2021
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Polymicrobial interactions between commensal obligate anaerobic bacteria and cystic fibrosis pathogen P. aeruginosa
共生专性厌氧菌与囊性纤维化病原体铜绿假单胞菌之间的多种微生物相互作用
  • 批准号:
    10275319
  • 财政年份:
    2021
  • 资助金额:
    $ 79.42万
  • 项目类别:
Platform for the automated isolation and characterization of anaerobic bacteria
厌氧菌自动分离和表征平台
  • 批准号:
    445552570
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Major Research Instrumentation
Development of therapy for triple negative breast cancer using anaerobic bacteria
利用厌氧菌开发三阴性乳腺癌疗法
  • 批准号:
    19K16452
  • 财政年份:
    2019
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of gene engineering method for anaerobic bacteria for efficient bio-hydrogen production
开发厌氧菌高效生物制氢的基因工程方法
  • 批准号:
    18K11708
  • 财政年份:
    2018
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了